ENDRA Life Sciences (NASDAQ:NDRA) Shares Up 1.9% – What’s Next?

Shares of ENDRA Life Sciences Inc. (NASDAQ:NDRA) traded up 1.9% on Tuesday . The company traded as high as $3.30 and last traded at $3.17. 89,934 shares traded hands during trading, a decline of 36% from the average session volume of 141,303 shares. The stock had previously closed at $3.11.

Wall Street Analysts Forecast Growth

Separately, Ascendiant Capital Markets lowered their price objective on ENDRA Life Sciences from $75.00 to $50.00 and set a “buy” rating on the stock in a research report on Monday, April 21st.

ENDRA Life Sciences Trading Up 1.9%

The stock has a 50 day simple moving average of $4.12 and a 200-day simple moving average of $4.77. The firm has a market cap of $2.34 million, a P/E ratio of 0.00 and a beta of 0.19.

ENDRA Life Sciences (NASDAQ:NDRA) last issued its earnings results on Monday, March 31st. The company reported ($9.40) earnings per share for the quarter, missing the consensus estimate of ($4.10) by ($5.30). As a group, equities analysts forecast that ENDRA Life Sciences Inc. will post -47.46 earnings per share for the current fiscal year.

ENDRA Life Sciences Company Profile

ENDRA Life Sciences Inc develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.